These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30511687)

  • 21. HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus.
    Hrycek A; Siekiera U; Cieślik P; Szkróbka W
    Rheumatol Int; 2005 Nov; 26(1):1-6. PubMed ID: 15449022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmunogenic HLA-DRB1*0301 allele (DR3) may be distinguished at the DRB1 non-coding regions of HLA-B8,DR3,Dw24 and B18,DR3,Dw25 haplotypes.
    Segurado OG; Iglesias-Casarrubios P; Martinez-Laso J; Corell A; Martin-Villa JM; Arnaiz-Villena A
    Mol Immunol; 1991; 28(1-2):189-92. PubMed ID: 1672728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of autoantibody profile with HLA-DRB1 and -DQB1 alleles in a group of Iranian systemic lupus erythematosus patients.
    Rasouli-Saravani A; Tahamoli-Roudsari A; Basiri Z; Babaei M; Fazaeli A; Roshanaei G; Hajilooi M; Solgi G
    Immunol Lett; 2021 Sep; 237():11-16. PubMed ID: 34186156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03.
    Furukawa H; Kawasaki A; Oka S; Ito I; Shimada K; Sugii S; Hashimoto A; Komiya A; Fukui N; Kondo Y; Ito S; Hayashi T; Matsumoto I; Kusaoi M; Amano H; Nagai T; Hirohata S; Setoguchi K; Kono H; Okamoto A; Chiba N; Suematsu E; Katayama M; Migita K; Suda A; Ohno S; Hashimoto H; Takasaki Y; Sumida T; Nagaoka S; Tsuchiya N; Tohma S
    PLoS One; 2014; 9(2):e87792. PubMed ID: 24498373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test.
    Tsuchiya N; Kawasaki A; Tsao BP; Komata T; Grossman JM; Tokunaga K
    Genes Immun; 2001 Oct; 2(6):317-22. PubMed ID: 11607787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha.
    Wilson AG; Gordon C; di Giovine FS; de Vries N; van de Putte LB; Emery P; Duff GW
    Eur J Immunol; 1994 Jan; 24(1):191-5. PubMed ID: 8020556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief Report: Influence of HLA-DRB1 Susceptibility Alleles on the Clinical Subphenotypes of Systemic Lupus Erythematosus in Koreans.
    Bang SY; Choi JY; Park S; Choi J; Hong SJ; Lee HS; Choi CB; Bae SC
    Arthritis Rheumatol; 2016 May; 68(5):1190-6. PubMed ID: 26663868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
    Lee YH; Bae SC; Song GG
    Rheumatol Int; 2015 Jun; 35(6):953-61. PubMed ID: 25326335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility.
    Vargas-Alarcón G; Salgado N; Granados J; Gómez-Casado E; Martinez-Laso J; Alcocer-Varela J; Arnaiz-Villena A; Alarcón-Segovia D
    Hum Immunol; 2001 Aug; 62(8):814-20. PubMed ID: 11476905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in HLA-DRB1 gene and the risk of tuberculosis: a meta-analysis of 31 studies.
    Tong X; Chen L; Liu S; Yan Z; Peng S; Zhang Y; Fan H
    Lung; 2015 Apr; 193(2):309-18. PubMed ID: 25787085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Relevance of HLA-DRB1 and -DQB1 Alleles in Iranian Systemic Lupus Erythematosus Patients.
    Rasouli-Saravani A; Tahamoli-Roudsari A; Behzad M; Hajilooi M; Solgi G
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):67-75. PubMed ID: 33639633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients.
    Salgado-Galicia NA; Hernández-Doño S; Ruiz-Gómez D; Jakez-Ocampo J; Zúñiga J; Vargas-Alarcón G; Acuña V; Hernández MT; Márquez-García JE; García-Lechuga M; Llorente L; Lima G; Pineda C; Yu N; Yunis E; Granados J
    Clin Rheumatol; 2020 Jul; 39(7):2151-2161. PubMed ID: 32008155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetic contribution of HLA-DRB5*01:01 to systemic lupus erythematosus in Thailand.
    Louthrenoo W; Kasitanon N; Wichainun R; Wangkaew S; Sukitawut W; Ohnogi Y; Hong GH; Kuwata S; Takeuchi F
    Int J Immunogenet; 2013 Apr; 40(2):126-30. PubMed ID: 22862923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal HLA class II compatibility in men with systemic lupus erythematosus.
    Stevens AM; Tsao BP; Hahn BH; Guthrie K; Lambert NC; Porter AJ; Tylee TS; Nelson JL
    Arthritis Rheum; 2005 Sep; 52(9):2768-73. PubMed ID: 16142706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent association of HLA-DR and FCgamma receptor polymorphisms in Korean patients with systemic lupus erythematosus.
    Lee HS; Chung YH; Kim TG; Kim TH; Jun JB; Jung S; Bae SC; Yoo DH
    Rheumatology (Oxford); 2003 Dec; 42(12):1501-7. PubMed ID: 12867584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-A*33-DR3 and A*33-DR9 haplotypes enhance the risk of type 1 diabetes in Han Chinese.
    Zhang J; Zhao L; Wang B; Gao J; Wang L; Li L; Cui B; Hu M; Hong J; Gu W; Wang W; Ning G
    J Diabetes Investig; 2016 Jul; 7(4):514-21. PubMed ID: 27181214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of maternal-offspring HLA compatibility, parent-of-origin effects, and noninherited maternal antigen effects for HLA-DRB1 in systemic lupus erythematosus.
    Bronson PG; Komorowski LK; Ramsay PP; May SL; Noble J; Lane JA; Thomson G; Claas FH; Seldin MF; Kelly JA; Harley JB; Moser KL; Gaffney PM; Behrens T; Criswell LA; Barcellos LF
    Arthritis Rheum; 2010 Jun; 62(6):1712-7. PubMed ID: 20191587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population.
    Fojtíková M; Novota P; Cejková P; Pešičková S; Tegzová D; Cerná M
    Rheumatol Int; 2011 Sep; 31(9):1195-201. PubMed ID: 20352225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?
    da Silva Bernardes M; Antão Paiva CL; Ribeiro Paradela E; Papais Alvarenga M; Ferreira Pereira F; Vasconcelos CC; Papais Alvarenga RM
    J Neuroimmunol; 2019 May; 330():74-80. PubMed ID: 30836273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HLA-DRB1*1502-DQB1*0501 haplotype with susceptibility to systemic lupus erythematosus in Thais.
    Sirikong M; Tsuchiya N; Chandanayingyong D; Bejrachandra S; Suthipinittharm P; Luangtrakool K; Srinak D; Thongpradit R; Siriboonrit U; Tokunaga K
    Tissue Antigens; 2002 Feb; 59(2):113-7. PubMed ID: 12028537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.